How to Buy Verve Therapeutics Stock
Verve Therapeutics Inc
Verve Therapeutics, Inc. , a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases.
Verve Therapeutics stock last closed at $11.09, down 0.36% from the previous day, and has increased 76.59% in one year. It has overperformed other stocks in the Biotechnology industry by 1.48 percentage points. Verve Therapeutics stock is currently +287.09% from its 52-week low of $2.87, and -2.76% from its 52-week high of $11.41.
There are currently 89.14M VERV shares outstanding. The market value of VERV is $988.60M. In the past 24 hours, 2.65M VERV shares were traded.
How to Buy Verve Therapeutics Stock
Wondering how to invest in Verve Therapeutics stock? Here's how.
- Figure out where to buy Verve Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you choose where to buy Verve Therapeutics stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Fund your brokerage account: Pick your method of payment and add your details.
- Research Verve Therapeutics stock: The Verve Therapeutics ticker symbol is VERV. Is Verve Therapeutics stock a good investment? Should you buy shares of VERV? How do VERV's underlying business fundamentals look? Do top analysts think Verve Therapeutics is a good buy? Why has VERV's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if VERV is a good stock to buy).
- Place your VERV purchase: Decide if you will purchase VERV shares at the current market price or use a limit order to purchase VERV shares at a particular price.
- Get updates on your VERV investment: Create a watchlist to get the latest news on your position in Verve Therapeutics stock.
Step 1: Figure out where to buy Verve Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy VERV stock.
Our recommended brokerage: eToro
Based on our research, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Technology to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've selected your brokerage, the next step is to fill out some personal information so you can invest in VERV today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to start a new brokerage account.
- Send your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have opened your account on the best stock app to use, you need to deposit funds:
Watch the walkthrough below to see the process of transferring money into your investment account.
Step 4: Research Verve Therapeutics stock
After you have identified the best place to buy Verve Therapeutics stock, it's crucial to research their stock before you buy, so you can understand the risk and opportunity.
Verve Therapeutics Numbers
VERV Fundamentals
WallStreetZen was built to help average investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on VERV's stock page.
Is VERV stock undervalued?
Investors use many financial metrics, analyses, models, and charts to gauge VERV's true value.
Using relative valuations methods:
- VERV could be undervalued based on its P/B ratio of 2.09x, relative to Biotechnology industry P/B ratio of 4.66x
You can do more valuation analysis on VERV's stock here.
A look at VERV Cashflows and Balance Sheet
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the VERV balance sheet.
- There are more short-term assets than short-term liabilities on the VERV balance sheet.
- VERV has $501.85M in cash and short term investments. This is enough to cover its annual cash burn of $146.98M.
- VERV has a low debt to equity ratio of 0.3.
- VERV has cash burn of 146982000. It has enough cash and short-term investments to cover this for at least one year.
Failed Financial Due Diligence Checks:
- VERV profit margin has gone up by 9.23 percentage points in the past year, but the company is still unprofitable.
Is Verve Therapeutics stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 7 Equities analysts who give forecasts on VERV, the consensus analyst rating on VERV is a Buy
Please note that analyst ratings are not recommendations, nor are they financial advice.
Most Recent VERV Analyst Recommendations
Etzer Darout, a top 14% analyst from Guggenheim maintains VERV with a strong buy rating and raises their VERV price target from $18.00 to $24.00, on Apr 15, 2025.
Guggenheim's Etzer Darout raised their price target on Verve Therapeutics (NASDAQ: VERV) by 33.3% from $18 to $24 on 2025/04/15. The analyst maintained their Strong Buy rating on the stock.
According to Darout, VERVE-102's headline Heart-2 Phase 1b results "provided a strikingly clean win" for Verve Therapeutics.
In light of the data, the analyst told readers they revised their original success probability estimate from 60% to 75%.
Luca Issi, a bottom 2% analyst from RBC Capital maintains VERV with a buy rating and lowers their VERV price target from $17.00 to $15.00, on Mar 4, 2025.
You can dig deeper into what analysts are projecting on the Verve Therapeutics stock forecast page.
VERV Momentum
VERV Revenue
Last year, VERV revenue was $59.61M. During the past 2 year, VERV's revenue has grown by 322.16% per year. This was faster than the Biotechnology industry average of 43.87%.
Find out more about VERV's earnings and revenue performance here.
Who is buying/selling VERV?
Over the last year, executives and large shareholders at VERV have sold more shares than they have bought.
Andrew D. Ashe, President Chief Operating Officer and General Counsel of VERV, was the latest VERV insider to sell. They sold $11,126.15 worth of VERV shares on Apr 2, 2025.
Learn more about who owns VERV shares here.
Does VERV provide a stable income stream?
No, Verve Therapeutics doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your VERV purchase
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally the best for newer investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at an exact dollar amount, use a limit order.
Click the Open button and your broker will place the order.
If you need more assistance investing in stocks on eToro, watch the how to video below:
Step 6: Get updates on your VERV investment
Now that you own some VERV stock, you'll want to keep up with your new shares.
Start a watchlist to keep tabs on your VERV stock.
VERV Feed
How to Buy Stock in Verve Therapeutics
To summarize, here are the 6 steps to buy Verve Therapeutics stock:
- Figure out where to buy Verve Therapeutics stock
- Create a brokerage account
- Fund your brokerage account
- Research Verve Therapeutics stock
- Place your VERV purchase
- Get updates on your VERV investment
If you require a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Verve Therapeutics, add VERV to your watchlist by clicking the button below.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.